The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Immunoglobulins
".
FunFam 33: Killer cell immunoglobulin-like receptor
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 20 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
39 |
P43626 (/IPI)
P43626 (/IPI)
P43628 (/IPI)
P43628 (/IPI)
P43629 (/IPI)
P43629 (/IPI)
P43629 (/IPI)
P43629 (/IPI)
P43629 (/IPI)
P43629 (/IPI)
(29 more) |
Coreceptor activity GO:0015026
Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity.
|
12 |
Q925N6 (/IDA)
Q925N6 (/IDA)
Q925N6 (/IDA)
Q925N6 (/IDA)
Q925N6 (/IDA)
Q925N6 (/IDA)
Q925N6 (/IDA)
Q925N6 (/IDA)
Q925N6 (/IDA)
Q925N6 (/IDA)
(2 more) |
Coreceptor activity GO:0015026
Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity.
|
12 |
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
(2 more) |
Inhibin binding GO:0034711
Interacting selectively and non-covalently with an inhibin monomer, any of the polypeptides that combine to form activin and inhibin dimers.
|
12 |
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
(2 more) |
Inhibin binding GO:0034711
Interacting selectively and non-covalently with an inhibin monomer, any of the polypeptides that combine to form activin and inhibin dimers.
|
12 |
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
(2 more) |
Activin receptor antagonist activity GO:0038102
Interacting with an activin receptor complex to reduce the action of another ligand, the agonist. A receptor antagonist does not initiate signaling upon binding to a receptor, but instead blocks an agonist from binding to the receptor.
|
12 |
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
(2 more) |
Activin receptor antagonist activity GO:0038102
Interacting with an activin receptor complex to reduce the action of another ligand, the agonist. A receptor antagonist does not initiate signaling upon binding to a receptor, but instead blocks an agonist from binding to the receptor.
|
12 |
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
(2 more) |
MHC class Ib protein binding GO:0023029
Interacting selectively and non-covalently with major histocompatibility complex class Ib molecules.
|
8 | P43630 (/IDA) P43630 (/IDA) P43630 (/IDA) P43630 (/IDA) P43630 (/IDA) P43630 (/IDA) P43632 (/IDA) P43632 (/IDA) |
HLA-B specific inhibitory MHC class I receptor activity GO:0030109
Combining with a MHC class I molecule of the HLA-B subclass to mediate signaling that inhibits activation of a lymphocyte.
|
6 | P43629 (/NAS) P43629 (/NAS) P43629 (/NAS) P43629 (/NAS) P43629 (/NAS) P43629 (/NAS) |
Signaling receptor activity GO:0038023
Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
|
6 | P43626 (/TAS) P43626 (/TAS) P43628 (/TAS) P43628 (/TAS) Q8NHJ6 (/TAS) Q9HCN6 (/TAS) |
Transmembrane signaling receptor activity GO:0004888
Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
|
4 | P43631 (/NAS) P43631 (/NAS) Q14954 (/NAS) Q9UNC3 (/NAS) |
Antigen binding GO:0003823
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
|
3 | P43628 (/TAS) P43628 (/TAS) Q8NHJ6 (/TAS) |
Transmembrane signaling receptor activity GO:0004888
Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
|
3 | Q99706 (/TAS) Q99706 (/TAS) Q9HCN6 (/TAS) |
HLA-C specific inhibitory MHC class I receptor activity GO:0030110
Combining with a MHC class I molecule of the HLA-C subclass to mediate signaling that inhibits activation of a lymphocyte.
|
3 | Q14953 (/NAS) Q9UNC0 (/NAS) Q9UNC4 (/NAS) |
MHC class I receptor activity GO:0032393
Combining with an MHC class I protein complex to initiate a change in cellular activity. Class I here refers to classical class I molecules.
|
3 | Q14943 (/NAS) Q14943 (/NAS) Q14943 (/NAS) |
MHC class Ib receptor activity GO:0032394
Combining with an MHC class Ib protein complex and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.
|
2 | Q99706 (/IDA) Q99706 (/IDA) |
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
|
1 | P0C191 (/IDA) |
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
|
1 | Q9HCN6 (/TAS) |
Collagen receptor activity GO:0038064
Combining with a collagen and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
1 | P0C191 (/IMP) |
Gamma-tubulin binding GO:0043015
Interacting selectively and non-covalently with the microtubule constituent protein gamma-tubulin.
|
1 | Q8MK19 (/ISS) |
There are 36 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Regulation of immune response GO:0050776
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
23 |
P43626 (/TAS)
P43626 (/TAS)
P43627 (/TAS)
P43627 (/TAS)
P43628 (/TAS)
P43628 (/TAS)
P43629 (/TAS)
P43629 (/TAS)
P43629 (/TAS)
P43629 (/TAS)
(13 more) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
14 |
P43629 (/NAS)
P43629 (/NAS)
P43629 (/NAS)
P43629 (/NAS)
P43629 (/NAS)
P43629 (/NAS)
P43631 (/NAS)
P43631 (/NAS)
Q14943 (/NAS)
Q14943 (/NAS)
(4 more) |
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
|
12 |
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
(2 more) |
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
|
12 |
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
(2 more) |
Negative regulation of activin receptor signaling pathway GO:0032926
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
12 |
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
(2 more) |
Negative regulation of activin receptor signaling pathway GO:0032926
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
12 |
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
(2 more) |
Cellular defense response GO:0006968
A defense response that is mediated by cells.
|
10 | P43630 (/TAS) P43630 (/TAS) P43630 (/TAS) P43630 (/TAS) P43630 (/TAS) P43630 (/TAS) Q14952 (/TAS) Q14952 (/TAS) Q99706 (/TAS) Q99706 (/TAS) |
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
|
9 | P43631 (/TAS) P43631 (/TAS) P43632 (/TAS) P43632 (/TAS) Q14943 (/TAS) Q14943 (/TAS) Q14943 (/TAS) Q14953 (/TAS) Q14954 (/TAS) |
Natural killer cell mediated cytotoxicity GO:0042267
The directed killing of a target cell by a natural killer cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
|
6 | P43629 (/IMP) P43629 (/IMP) P43629 (/IMP) P43629 (/IMP) P43629 (/IMP) P43629 (/IMP) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
6 | P43630 (/IMP) P43630 (/IMP) P43630 (/IMP) P43630 (/IMP) P43630 (/IMP) P43630 (/IMP) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
4 | P43626 (/TAS) P43626 (/TAS) P43628 (/TAS) P43628 (/TAS) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
3 | Q8NHJ6 (/TAS) Q99706 (/TAS) Q99706 (/TAS) |
Natural killer cell activation GO:0030101
The change in morphology and behavior of a natural killer cell in response to a cytokine, chemokine, cellular ligand, or soluble factor.
|
3 | Q14943 (/NAS) Q14943 (/NAS) Q14943 (/NAS) |
Positive regulation of natural killer cell cytokine production GO:0002729
Any process that activates or increases the frequency, rate, or extent of natural killer cell cytokine production.
|
2 | Q99706 (/IDA) Q99706 (/IDA) |
Natural killer cell inhibitory signaling pathway GO:0002769
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of a natural killer cell capable of inhibiting an immune effector process contributing to an immune response.
|
2 | P43626 (/IDA) P43626 (/IDA) |
Negative regulation of natural killer cell mediated cytotoxicity GO:0045953
Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity.
|
2 | Q99706 (/IDA) Q99706 (/IDA) |
Positive regulation of cellular senescence GO:2000774
Any process that activates or increases the frequency, rate or extent of cellular senescence.
|
2 | Q99706 (/IDA) Q99706 (/IDA) |
Mitotic cytokinesis GO:0000281
A cell cycle process that results in the division of the cytoplasm of a cell after mitosis, resulting in the separation of the original cell into two daughter cells.
|
1 | Q8MK19 (/ISS) |
Nucleotide-excision repair GO:0006289
A DNA repair process in which a small region of the strand surrounding the damage is removed from the DNA helix as an oligonucleotide. The small gap left in the DNA helix is filled in by the sequential action of DNA polymerase and DNA ligase. Nucleotide excision repair recognizes a wide range of substrates, including damage caused by UV irradiation (pyrimidine dimers and 6-4 photoproducts) and chemicals (intrastrand cross-links and bulky adducts).
|
1 | Q8MK19 (/ISS) |
Double-strand break repair GO:0006302
The repair of double-strand breaks in DNA via homologous and nonhomologous mechanisms to reform a continuous DNA helix.
|
1 | Q8MK19 (/ISS) |
Defense response GO:0006952
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
|
1 | Q9UNC4 (/NAS) |
Enzyme linked receptor protein signaling pathway GO:0007167
Any series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell, where the receptor possesses catalytic activity or is closely associated with an enzyme such as a protein kinase, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q9HCN6 (/TAS) |
Blood coagulation GO:0007596
The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
|
1 | Q9HCN6 (/TAS) |
Platelet activation GO:0030168
A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
|
1 | Q9HCN6 (/NAS) |
Platelet activation GO:0030168
A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
|
1 | Q9HCN6 (/TAS) |
Negative regulation of mammary gland epithelial cell proliferation GO:0033600
Any process that stops, prevents or reduces the rate or extent of mammary gland epithelial cell proliferation.
|
1 | Q8MK19 (/ISS) |
Collagen-activated tyrosine kinase receptor signaling pathway GO:0038063
A series of molecular signals initiated by the binding of collagen to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
1 | P0C191 (/IMP) |
Collagen-activated signaling pathway GO:0038065
A series of molecular signals initiated by collagen binding to a cell surface receptor, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P0C191 (/IMP) |
Positive regulation of regulatory T cell differentiation GO:0045591
Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.
|
1 | Q8NHJ6 (/IDA) |
Negative regulation of osteoclast differentiation GO:0045671
Any process that stops, prevents, or reduces the frequency, rate or extent of osteoclast differentiation.
|
1 | Q8NHJ6 (/IDA) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | Q8MK19 (/ISS) |
Negative regulation of T cell receptor signaling pathway GO:0050860
Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
|
1 | Q8NHJ6 (/IDA) |
Leukocyte migration GO:0050900
The movement of a leukocyte within or between different tissues and organs of the body.
|
1 | Q9HCN6 (/TAS) |
Centrosome duplication GO:0051298
The replication of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized.
|
1 | Q8MK19 (/ISS) |
Negative regulation of protein localization to nucleus GO:1900181
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to nucleus.
|
1 | Q8NHJ6 (/IDA) |
Negative regulation of pri-miRNA transcription by RNA polymerase II GO:1902894
Any process that stops, prevents or reduces the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
|
1 | Q8NHJ6 (/IDA) |
There are 24 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
30 |
P43626 (/TAS)
P43626 (/TAS)
P43627 (/TAS)
P43627 (/TAS)
P43628 (/TAS)
P43628 (/TAS)
P43629 (/TAS)
P43629 (/TAS)
P43629 (/TAS)
P43629 (/TAS)
(20 more) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
17 |
P43626 (/TAS)
P43626 (/TAS)
P43628 (/TAS)
P43628 (/TAS)
P43630 (/TAS)
P43630 (/TAS)
P43630 (/TAS)
P43630 (/TAS)
P43630 (/TAS)
P43630 (/TAS)
(7 more) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
13 |
P43629 (/NAS)
P43629 (/NAS)
P43629 (/NAS)
P43629 (/NAS)
P43629 (/NAS)
P43629 (/NAS)
Q14943 (/NAS)
Q14943 (/NAS)
Q14943 (/NAS)
Q14953 (/NAS)
(3 more) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
12 |
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
Q8N6C5 (/IDA)
(2 more) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
12 |
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
Q7TQA1 (/ISO)
(2 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
4 | P43626 (/IDA) P43626 (/IDA) Q14953 (/IDA) Q14954 (/IDA) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
3 | P43631 (/NAS) P43631 (/NAS) Q14954 (/NAS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | Q19LI2 (/ISO) Q19LI2 (/ISO) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
2 | Q99706 (/HDA) Q99706 (/HDA) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
2 | P43628 (/TAS) P43628 (/TAS) |
Early endosome membrane GO:0031901
The lipid bilayer surrounding an early endosome.
|
2 | Q99706 (/IDA) Q99706 (/IDA) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
2 | Q8NHJ6 (/HDA) Q9HCN6 (/HDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | Q9EPH1 (/ISS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | Q8MK19 (/ISS) |
Centrosome GO:0005813
A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
|
1 | Q8MK19 (/ISS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
1 | Q8NHJ6 (/NAS) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | P0C191 (/IDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
1 | Q9HCN6 (/HDA) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | Q14953 (/IDA) |
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
|
1 | Q8MK19 (/ISS) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
1 | Q8MK19 (/ISS) |
BRCA2-MAGE-D1 complex GO:0033593
A heterodimeric protein complex formed of BRCA2 and MAGE-D1; may mediate the synergistic activities of the two proteins in regulating cell growth.
|
1 | Q8MK19 (/ISS) |
Tetraspanin-enriched microdomain GO:0097197
A pre-organized unit composed either of adhesion molecules (mainly integrins and members of the Ig superfamily), signaling receptors and/or enzyme-enriched plasma membrane domains that compartmentalizes cellular processes. Tetraspanin-enriched microdomains might be specially suited for the regulation of avidity of adhesion receptors and the compartmentalization of enzymatic activities.
|
1 | Q9HCN6 (/IDA) |
Tetraspanin-enriched microdomain GO:0097197
A pre-organized unit composed either of adhesion molecules (mainly integrins and members of the Ig superfamily), signaling receptors and/or enzyme-enriched plasma membrane domains that compartmentalizes cellular processes. Tetraspanin-enriched microdomains might be specially suited for the regulation of avidity of adhesion receptors and the compartmentalization of enzymatic activities.
|
1 | P0C191 (/ISO) |